ProximiTx

ProximiTx is a biotech team developing a novel targeted protein degradation (TPD) platform to treat diseases like hepatocellular carcinoma (HCC). Their approach selectively degrades disease-causing proteins, potentially allowing for curative treatments and expanding the druggable protein landscape.